---
title: "Fennec Pharmaceuticals Director Rosty Raykov Reports Disposal of Common Shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/274562415.md"
datetime: "2026-02-02T21:55:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/274562415.md)
  - [en](https://longbridge.com/en/news/274562415.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/274562415.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/274562415.md) | [繁體中文](https://longbridge.com/zh-HK/news/274562415.md)


# Fennec Pharmaceuticals Director Rosty Raykov Reports Disposal of Common Shares

Rosty Raykov, a Director of Fennec Pharmaceuticals Inc., has reported a disposal of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fennec Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001468316-26-000006), on February 02, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [Fennec Pharmaceuticals Inc. (FENC.US)](https://longbridge.com/en/quote/FENC.US.md)

## Related News & Research

- [Southpoint Capital Advisors Reports Sale of Fennec Pharmaceuticals Common Shares](https://longbridge.com/en/news/271032490.md)
- [Christopher John Kenney Sells 1,410 Shares of Xenon Pharmaceuticals (NASDAQ:XENE) Stock](https://longbridge.com/en/news/279106095.md)
- [Centessa Pharmaceuticals Executives Sell Shares](https://longbridge.com/en/news/279098050.md)
- [Arrowhead Pharmaceuticals CMO Sells 10,000 Shares](https://longbridge.com/en/news/278458045.md)
- [437,391 Shares in Amylyx Pharmaceuticals, Inc. $AMLX Purchased by Ally Bridge Group NY LLC](https://longbridge.com/en/news/279145068.md)